[disseminated choroiditis, papillitis and vasculitis retinae as main findings in lues ii-iii]

NLM AIDSLINE [Disseminated choroiditis, papillitis and vasculitis retinae as main findings in lues II-III] Bialasiewicz AA; Dommer S; Augenklinik mit Poliklinik,
August 30, 1991

Klin Monatsbl Augenheilkd. 1991 Jan;198(1):37-43. Unique Identifier : Intraocular inflammations as chief manifestation of a T. pallidum infection associated with stage II syphilis are rarely documented in the recent literature. We report on a 35 year old patient with bilateral choroiditis, retinal vasculitis and papillitis persisting retrospectively since he had received some medication for syphilis 8 years previously. This patient was at high risk for other sexually transmitted diseases, however, he did not show HIV-seroconversion. General symptoms like uneasiness, fatigue, depressions and intermittent weight loss were mentioned. Reduction of visual acuity with topical corticosteroid therapy led to another medical work-up, and a systemic therapy with Ceftriaxone for 14 days resulted in better vision, better perimetric results and less inflammatory cell in the vitreous but evident optic atrophy. Adult Case Report Ceftriaxone/THERAPEUTIC USE Chorioretinitis/DIAGNOSIS/DRUG THERAPY Drug Therapy, Combination English Abstract Follow-Up Studies Human Male Methylprednisolone/THERAPEUTIC USE Neurosyphilis/DIAGNOSIS/DRUG THERAPY Papilledema/*DIAGNOSIS/DRUG THERAPY Retinal Detachment/DIAGNOSIS/DRUG THERAPY Syphilis Serodiagnosis Visual Acuity/DRUG EFFECTS Visual Fields/DRUG EFFECTS JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV No time to lose in the search for an HIV vaccine India Widens Price Control Over Medicines Health group didn't disclose HIV tests, apologizes As Hepatitis C Spreads, Scotland Steps In Russia has 'no anti-AIDS strategy': official Uganda: Over 600 Circumcised in Masaka 1 new hepatitis case in Okla. public health scare NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs Researchers from Albert Einstein College of Medicine Report Details of New Studies and Findings in the Area of HIV/AIDS Findings from Northwestern University Broaden Understanding of HIV/AIDS New Sexually Transmitted Diseases (STDs) Findings Reported from Department of Genitourinary Medicine and Infectious Diseases New Findings from A.M. Cavalcanti and Colleagues Has Provided New Data on Genetics and HIV/AIDS Cannabis Science Announces Screening of 'American Drug War II,' Film by Kevin Booth, on Thursday, April 18 Investigators at Johns Hopkins University Bloomberg School of Public Health Report Findings in HAART Findings from London School of Hygiene and Tropical Medicine Reveals New Findings on AIDS/HIV Research Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection Researchers from Albert Einstein College of Medicine Detail New Studies and Findings in the Area of AIDS/HIV Research Ohr Pharmaceutical Announces Results from OHR/AVR118 Phase II Trial in Cancer Cachexia
Information in this article was accurate in August 30, 1991. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.